These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 32629021)

  • 1. Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan.
    Allocca M; Guidelli GM; Borroni RG; Selmi C; Narcisi A; Danese S; Fiorino G
    Pharmacol Res; 2020 Oct; 160():105061. PubMed ID: 32629021
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19: a case for inhibiting IL-17?
    Pacha O; Sallman MA; Evans SE
    Nat Rev Immunol; 2020 Jun; 20(6):345-346. PubMed ID: 32358580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe COVID-19 disease and thromboinflammation.
    Jerjes-Sánchez C
    Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
    [No Abstract]   [Full Text] [Related]  

  • 4. The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond.
    Bellanti JA; Settipane RA
    Allergy Asthma Proc; 2020 Nov; 41(6):395-396. PubMed ID: 33109305
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
    Abid MB; Mughal M; Abid MA
    JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19.
    Gatto L; Franceschi E; Nunno VD; Brandes AA
    Immunotherapy; 2020 Oct; 12(15):1111-1114. PubMed ID: 32594820
    [No Abstract]   [Full Text] [Related]  

  • 7. Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
    Haberman R; Axelrad J; Chen A; Castillo R; Yan D; Izmirly P; Neimann A; Adhikari S; Hudesman D; Scher JU
    N Engl J Med; 2020 Jul; 383(1):85-88. PubMed ID: 32348641
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity, COVID-19 and immunotherapy: the complex relationship!
    Finelli C
    Immunotherapy; 2020 Oct; 12(15):1105-1109. PubMed ID: 32677493
    [No Abstract]   [Full Text] [Related]  

  • 9. Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism.
    Gouse BM; Spears WE; Nieves Archibald A; Montalvo C
    Brain Behav Immun; 2020 Oct; 89():529-530. PubMed ID: 32791211
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
    Foldes D; Hinton R; Arami S; Bain BJ
    Am J Hematol; 2020 Jul; 95(7):861-862. PubMed ID: 32298486
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
    Mozzini C; Girelli D
    Thromb Res; 2020 Jul; 191():26-27. PubMed ID: 32360977
    [No Abstract]   [Full Text] [Related]  

  • 12. An Italian programme for COVID-19 infection in multiple sclerosis.
    Sormani MP;
    Lancet Neurol; 2020 Jun; 19(6):481-482. PubMed ID: 32359409
    [No Abstract]   [Full Text] [Related]  

  • 13. Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?
    Nilashi M; Samad S; Yusuf SYM; Akbari E
    J Infect Public Health; 2020 Jun; 13(6):893-896. PubMed ID: 32451258
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke in COVID-19 patients-A case series from Italy.
    Immovilli P; Terracciano C; Zaino D; Marchesi E; Morelli N; Terlizzi E; De Mitri P; Vollaro S; Magnifico F; Colombi D; Michieletti E; Guidetti D
    Int J Stroke; 2020 Aug; 15(6):701-702. PubMed ID: 32568626
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the Editor: COVID-19 and the Neurosurgical Treatment of Idiopathic Normal Pressure Hydrocephalus: Shall We Continue to Postpone "Non-emergent" Surgical Procedures?
    La Corte E; Palandri G
    World Neurosurg; 2020 Sep; 141():578-579. PubMed ID: 32741739
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-Free Therapies: Novel Approaches for COVID-19.
    Maron-Gutierrez T; Rocco PRM
    Front Immunol; 2020; 11():583017. PubMed ID: 33072130
    [No Abstract]   [Full Text] [Related]  

  • 17. Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin.
    Aljaberi R; Wishah K
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):349-350. PubMed ID: 32505720
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex differences in COVID-19 course and outcome: progesterone should not be neglected.
    Jakovac H
    J Appl Physiol (1985); 2020 Nov; 129(5):1007-1008. PubMed ID: 33096966
    [No Abstract]   [Full Text] [Related]  

  • 19. We urgently need guidelines for managing COVID-19 in children with comorbidities.
    Dayal D
    Acta Paediatr; 2020 Jul; 109(7):1497-1498. PubMed ID: 32279351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor.
    Beccuti G; Ghizzoni L; Cambria V; Codullo V; Sacchi P; Lovati E; Mongodi S; Iotti GA; Mojoli F
    J Endocrinol Invest; 2020 Aug; 43(8):1175-1177. PubMed ID: 32519200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.